Mid-Day Breakouts Report - Tuesday, April 28th, 2020

<<<Previous Mid Day Report	Next Mid Day Report >>>
<<<Previous After Market Report	Next After Market Report >>>

You are not logged in.
This means you CAN ONLY VIEW reports that were published prior to Sunday, February 25, 2024.
You MUST UPGRADE YOUR MEMBERSHIP if you want to see any current reports.

MIDDAY BREAKOUTS REPORT - TUESDAY, APRIL 28TH, 2020
Previous Mid Day Report Next Mid Day Report >>>

DOW 24160.96 27.18 (0.11%) | NASDAQ 8657.15 -73.01 (-0.84%) | S&P 500 2874.09 -4.39 (-0.15%)

Time of Screening : 4/28/2020 12:15:47 PM Report Released : 4/28/2020 12:47:56 PM
Price is: Above 52W High and Less Than 52W High but within 15% of the 52 Week High
Volume Is: At least 57.5% of 50 Day Average at the time of the screening.
More details about this report...

To View Current Notes and Data on currently Featured Stocks go to the latest
Featured Stocks Page

Symbol/Exchange Company Name Industry Group	PRICE	CHANGE (%Change)	Day High	Volume (% DAV) (50 DAV)	52 Wk Hi % From Hi	Date Featured	Price Featured	Pivot Point
Symbol/Exchange Company Name Industry Group	PRICE	CHANGE (%Change)	Day High	Volume (% DAV) (50 DAV)	52 Wk Hi % From Hi	Date Featured	Price Featured	Max Buy
NFLX - NASDAQ Netflix Inc	$405.67	-15.71 -3.73%	$421.00	5,663,758 60.81% of 50 DAV 50 DAV is 9,314,000	$449.52 -9.75%	4/13/2020	$393.60	PP = $393.62 MB = $413.30
Most Recent Note - 4/28/2020 12:33:21 PM Y - Color code is changed to yellow while pulling back below its "max buy" level. Prior highs in the $393 area define important near-term support to watch. Fundamentals remain strong after it reported earnings +107% on +28% sales revenues for the Mar '20 quarter versus the year ago period. >>> The latest Featured Stock Update with an annotated graph appeared on 4/21/2020. Click here.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M

Symbol - Exchange - Industry Group Company Name	Last	Chg	Day High	52 WK Hi	% From Hi	Volume % DAV	DAV
AGN - NYSE - DRUGS - Drug Manufacturers - Other Allergan Inc	$187.08	-1.16 -0.62%	$189.41	$202.22	-7.49%	2,760,938 63.24%	4,366,000
Most Recent Note for AGN - 4/28/2020 12:17:07 PM Rebounded since undercutting its 200 DMA line when last noted with caution in the 3/16/20 mid-day report - "Reported earnings +22% on +7% sales revenues for the Dec '19 quarter. Prior quarterly earnings comparisons were well below the +25% minimum guideline (C criteria). After a downturn in FY '14 earnings its growth has been steady."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
AUDC - NASDAQ - ELECTRONICS - Scientific & Technical Instrum Audiocodes Ltd	$29.58	+0.82 2.85%	$29.82	$29.43	0.51%	434,837 83.46%	521,000
Most Recent Note for AUDC - 4/28/2020 12:18:13 PM Gapped up and hit a new 52-week high on the prior session and trading higher today. Fundamentals remain strong after it reported earnings +39% on +12% sales revenues for the Mar '20 quarter. Did not form a sound base pattern, yet faces no resistance due to overhead supply. Rebounded impressively after a deep pullback since dropped from the Featured Stocks list on 2/27/20.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
CGNX - NASDAQ - ELECTRONICS - Scientific & Technical Instrum Cognex Corp	$55.30	+5.46 10.96%	$57.68	$59.14	-6.49%	1,715,551 121.84%	1,408,000
Most Recent Note for CGNX - 4/28/2020 12:18:51 PM Gapped up today challenging its 52-week high. Quarterly comparisons have not shown strong and steady growth above the +25% minimum (C criteria) earnings guideline of the fact-based investment system.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
CNC - NYSE - HEALTH SERVICES - Health Care Plans Centene Corp	$67.99	-2.83 -4.00%	$70.03	$74.70	-8.98%	5,607,148 85.02%	6,595,000
Most Recent Note for CNC - 4/28/2020 12:21:03 PM Gapped down today, retreating from its all-time high after recently wedging higher. Reported earnings -35% on +41% sales revenues for the Mar '20 quarter, a 3rd consecutive comparison below .the +25% minimum guideline (C criteria). Shares split 2:1 on 2/07/19. Completed a new Public Offering on 5/03/18. Shares split 2-1 effective 2/20/15. Annual earnings history (A criteria) improved following a downturn for FY '09 and '10.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
DGICA - NASDAQ - Insurance-Prop/Cas/Titl Donegal Group Inc Cl A	$15.68	+0.51 3.36%	$15.68	$15.43	1.62%	33,070 70.36%	47,000
Most Recent Note for DGICA - 4/28/2020 12:22:05 PM Hitting a new 52-week high with today's big gain. Due to report earnings news. Prior mid-day reports cautioned members - "Prior quarterly sales revenues and earnings growth has not been strong and steady. Annual earnings (A criteria) history also has been up and down."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
EDU - NYSE - DIVERSIFIED SERVICES - Education &; Training Services New Orientl Edu&Tech Ads	$121.99	+1.95 1.62%	$127.83	$142.38	-14.32%	1,273,739 67.29%	1,893,000
Most Recent Note for EDU - 4/28/2020 12:23:41 PM Rebounding above its 50 and 200 DMA lines. Reported earnings +35% on +16% sales revenues for the Feb '20 quarter but fundamental concerns remain. Noted in prior mid-day reports - "This China-based Consumer Services - Education firm has been rebounding after a deep consolidation below its 200 DMA line. Fundamental concerns remain. Prior quarterly and annual earnings (C and A criteria) history is not a match with the fact-based investment system's guidelines. Has a new CEO as of 9/02/16."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
GV - AMEX - MATERIALS & CONSTRUCTION - Heavy Construction Goldfield Corp	$3.38	+0.05 1.50%	$3.40	$3.94	-14.21%	62,875 93.84%	67,000
Most Recent Note for GV - 4/28/2020 12:25:23 PM Showed much better sales revenues increases and earnings in the Sep and Dec '20 quarterly comparisons. Fundamentals fall short of the C and A criteria of the fact-based investment system. Low-priced stocks are discouraged from consideration unless solidly satisfying all key criteria.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
INCY - NASDAQ - DRUGS - Biotechnology Incyte Corporation	$97.32	-5.66 -5.49%	$104.36	$104.81	-7.14%	1,666,433 75.23%	2,215,000
Most Recent Note for INCY - 4/28/2020 12:27:08 PM Retreating after reaching a new 52-week high. The 4/09/20 mid-day report noted - "Recent quarterly comparisons through Dec '19 have not shown strong and steady earnings increases."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
LFVN - NASDAQ - Cosmetics/Personal Care Lifevantage Corp	$15.25	+2.39 18.58%	$15.75	$17.25	-11.59%	299,219 318.32%	94,000
Most Recent Note for LFVN - 4/28/2020 12:28:42 PM Rebounding toward its 52-week high with today's considerable gain backed by above average volume. Went through a deep pullback since last noted with caution in the 1/31/20 mid-day report - "Showed improved earnings increases in the 3 latest quarterly comparisons through Dec '19, but fundamental concerns remain due to sub par sales revenues growth and its up and down annual earnings (A criteria) history."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
LH - NYSE - HEALTH SERVICES - Medical Laboratories & Researc Laboratory Corp Of Amer	$177.09	-1.40 -0.78%	$187.70	$196.36	-9.81%	1,142,213 87.93%	1,299,000
Most Recent Note for LH - 4/28/2020 12:31:02 PM Due to report earnings news before the open on 4/29/20. Impressively rebounded near its all-time high following an abrupt retreat since noted with caution in the 3/06/20 mid-day report - "Dec '19 quarterly earnings rose +13% on +6% sales revenues. Prior quarterly earnings increases were below the +25% minimum guideline."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
PJT - NYSE - Finance-Investment Mgmt P J T Partners Inc Cl A	$50.13	+2.67 5.62%	$51.37	$53.21	-5.80%	211,264 90.67%	233,000
Most Recent Note for PJT - 4/28/2020 12:38:29 PM Reported earnings +176% on sales revenues +56% for the Mar '20 quarter, its 4th consecutive strong quarterly comparison versus the year ago period. Rebounding impressively toward its 52-week high after a deep pullback since last noted with caution in the 2/21/20 mid-day report - "Faces some resistance due to overhead supply up to the $61 level."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
QDEL - NASDAQ - DRUGS - Diagnostic Substances Quidel Corp	$131.92	-6.17 -4.47%	$140.07	$143.97	-8.37%	415,207 66.43%	625,000
Most Recent Note for QDEL - 4/28/2020 12:40:46 PM Pulling back today after spiking to new all-time highs with 6 consecutive gains backed by volume conviction. Due to report earnings news on 5/06/20. This San Diego, CA based maker of rapid diagnostic tests for infectious diseases has earned a high Earnings Per Share rating of 95. Reported earnings +23% on +15% sales revenues for the Dec '19 quarter and prior quarterly earnings comparisons were below the +25% minimum guideline (C criteria). Annual earnings (A criteria) history include a slight downturn in FY '19 following strong earnings growth in FY '17 and '18.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
SNFCA - NASDAQ - INSURANCE - Life Insurance Security Natl Finl Cl A	$5.46	+0.08 1.49%	$5.46	$6.42	-14.95%	13,011 130.11%	10,000
Most Recent Note for SNFCA - 4/28/2020 12:41:31 PM Faces resistance due to overhead supply. Erratic sales revenues and earnings history is not a match with the fact-based investment system's fundamental guidelines. Low-priced stocks are discouraged from consideration unless all key criteria are solidly satisfied.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
SNY - NYSE - DRUGS - Drug Manufacturers - Other Sanofi	$50.09	-0.54 -1.07%	$50.21	$51.84	-3.38%	2,975,400 94.55%	3,147,000
Most Recent Note for SNY - 4/28/2020 12:43:48 PM Reported earnings +46% on +5% sales revenues for the Mar '20 quarter. Prior quarterly and annual earnings (C and A criteria) history and sales revenues growth has been below the fundamental guidelines of the fact-based investment system.
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
TREX - NYSE - MATERIALS & CONSTRUCTION - General Building Materials Trex Company Inc	$96.04	+4.25 4.63%	$98.15	$111.85	-14.14%	702,952 70.22%	1,001,000
Most Recent Note for TREX - 4/28/2020 12:45:39 PM Due to report earnings news on 5/04/20. Rebounding toward its all-time high following a deep slump below its 50 and 200 DMA lines since last noted with caution in the 3/06/20 mid-day report - "Reported earnings +42% on +18% sales revenues for the Dec '19 quarter. Prior quarterly comparisons were not strong and steady above the +25% minimum earnings guideline (C criteria). Annual earnings (A criteria) growth has been strong after a downturn in FY '14."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
ZBRA - NASDAQ - COMPUTER HARDWARE - Computer Peripherals Zebra Tech Corp Cl A	$232.34	+11.41 5.16%	$238.23	$260.40	-10.78%	411,292 66.88%	615,000
Most Recent Note for ZBRA - 4/28/2020 12:47:11 PM Gapped up today. Reported earnings -9% on -1% sales revenues for the Mar '20 quarter and fundamental concerns remain. It was dropped from the Featured Stocks list on 5/09/19. Earnings for the 4 prior quarters were also below the +25% minimum earnings guideline (C criteria).
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M
ZYXI - NASDAQ - Medical-Products Zynex Inc	$16.72	+0.73 4.57%	$16.95	$16.21	3.15%	318,805 80.91%	394,000
Most Recent Note for ZYXI - 4/28/2020 12:47:52 PM Found prompt support near its 200 DMA line in recent weeks and rallied. Hitting another new 52-week high with today's 7th consecutive gain. Noted with caution in prior mid-day reports - "Reported earnings +13% on +52% sales revenues for the Dec '19 quarter, and prior quarterly comparisons were below the +25% minimum guideline (C criteria)."
View all notes \| Alert me of new notes \| Company Profile \| SEC \| News \| Chart \| C A N S L I M

THESE ARE NOT BUY RECOMMENDATIONS! Comments contained in the body of this report are technical opinions only. The material herein has been obtained from sources believed to be reliable and accurate, however, its accuracy and completeness cannot be guaranteed. We are not an investment advisor, hence it does not endorse or recommend any securities or other investments. Any recommendation contained in this report may not be suitable for all investors and it is not to be deemed an offer or solicitation on our part with respect to the purchase or sale of any securities. All trademarks, service marks and trade names appearing in this report are the property of their respective owners, and are likewise used for identification purposes only.

This report is a service available only to active Paid Premium Members. You may opt-out of receiving report notifications at any time. Questions or comments may be submitted by writing to FactBasedInvesting.com c/o Premium Member Services 665 S.E. 10 Street, Suite 201 Deerfield Beach, FL 33441-5634 or by calling 954-785-1121.

We appreciate any feedback members may wish to send via the inquiry form here.